Yüklüyor......
Effectiveness of Tocilizumab in a COVID-19 Patient with Cytokine Release Syndrome
Cytokine release syndrome (CRS) is a systemic inflammatory response that can be triggered by many factors such as infections. CRS in patients with coronavirus disease 2019 (COVID-19) is life-threatening and can occur very rapidly after COVID-19 diagnosis. Tocilizumab (TCZ), an interleukin-6 (IL-6) i...
Kaydedildi:
| Yayımlandı: | Eur J Case Rep Intern Med |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SMC Media Srl
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7279911/ https://ncbi.nlm.nih.gov/pubmed/32523930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12890/2020_001731 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|